Literature DB >> 3023239

Potential role of lysozyme in bactericidal activity of in vitro-acquired salivary pellicle against Streptococcus faecium 9790.

G R Germaine, L M Tellefson.   

Abstract

The adherence of Streptococcus faecium 9790 to hydroxyapatite (HA) coated with whole saliva supernatant proteins (S-HA) or parotid fluid proteins was studied. The organism was labeled with [3H]thymidine, and adherence was estimated as the radioactivity remaining associated with the variously coated HA preparations after incubation and removal of unbound microbes by washing the adherence substratum. Adherence was time dependent and saturable, characteristics typical of oral streptococci in this in vitro adherence model system. However, adherence to S-HA, but not bare HA, was decreased 20-fold at 4 degrees C compared with room temperature. Furthermore, adherence at 4 degrees C to S-HA was decreased 20-fold relative to bare HA at 4 degrees C. Adherence to HA coated with parotid fluid proteins also was reduced at 4 degrees C. The magnitude of the temperature dependence and the inhibitory effect at 4 degrees C of whole saliva or parotid fluid pellicles on HA was unexpected. Of several sugars and amino sugars tested, the chitin saccharides, chitotriose, chitobiose, and N-acetylglucosamine caused greater than 90% inhibition of adherence to S-HA. These same saccharides were previously shown to inhibit lysozyme, polylysine, or autolytic lysis of the organism (N. J. Laible and G. R. Germaine, Infect. Immun. 48:720-728, 1985). Examination of unbound and adherent microbes revealed that lysis of the organism occurred during the adherence assays. A strong association (r = 0.83) between the extent of lysis and the extent of adherence was found under a variety of conditions. Depletion of lysozyme from saliva specimens used to coat HA resulted in a greater than 90% decrease in both cell lysis and adherence. Lysis of the microbe appeared dependent upon the presence of the saliva pellicle (coating) on HA, since solutions containing proteins desorbed from HA during mock-adherence incubations possessed lytic activity that was 2- to 10-fold too low to account for the extents of lysis observed with greater than or equal to 10(8) input cells. These results demonstrate the potential antibacterial activity of acquired salivary pellicle on enamel in vivo and the likely role of lysozyme in this activity. The data also serve to caution that this widely used in vitro adherence model will not distinguish whole-cell adherence from the adsorption of radiolabeled DNA released from lysing cells. Several additional controls are suggested that will indicate whether test microbes remain intact or lyse during adherence trials.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3023239      PMCID: PMC260248          DOI: 10.1128/iai.54.3.846-854.1986

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  25 in total

1.  Studies on the bacterial components which bind Streptococcus sanguis and Streptococcus mutans to hydroxyapatite.

Authors:  W F Liljemark; S V Schauer
Journal:  Arch Oral Biol       Date:  1975-09       Impact factor: 2.633

Review 2.  Some factors associated with geographical variations in the intestinal microflora.

Authors:  B S Drasar
Journal:  Soc Appl Bacteriol Symp Ser       Date:  1974

3.  Parameters that effect the adherence of Streptococcus salivarius to oral epithelial surfaces.

Authors:  R J Gibbons; J Van Houte; W F Liljemark
Journal:  J Dent Res       Date:  1972 Mar-Apr       Impact factor: 6.116

4.  Sorption of bacteria to human enamel powder.

Authors:  J D Hillman; J Van Houte; R J Gibbons
Journal:  Arch Oral Biol       Date:  1970-09       Impact factor: 2.633

5.  Adherent interactions which may affect microbial ecology in the mouth.

Authors:  R J Gibbons
Journal:  J Dent Res       Date:  1984-03       Impact factor: 6.116

6.  Growth-inhibitory and bactericidal effects of human parotid salivary histidine-rich polypeptides on Streptococcus mutans.

Authors:  B J MacKay; L Denepitiya; V J Iacono; S B Krost; J J Pollock
Journal:  Infect Immun       Date:  1984-06       Impact factor: 3.441

7.  Adherence of Streptococcus sanguis to hydroxyapatite coated with lysozyme and lysozyme-supplemented saliva.

Authors:  L M Tellefson; G R Germaine
Journal:  Infect Immun       Date:  1986-03       Impact factor: 3.441

8.  Sorption of Streptococci to glass: Effects of macromolecular solutes.

Authors:  D Orstavik
Journal:  Acta Pathol Microbiol Scand B       Date:  1977-02

9.  Bactericidal activity of human lysozyme, muramidase-inactive lysozyme, and cationic polypeptides against Streptococcus sanguis and Streptococcus faecalis: inhibition by chitin oligosaccharides.

Authors:  N J Laible; G R Germaine
Journal:  Infect Immun       Date:  1985-06       Impact factor: 3.441

10.  Adsorption of lysozyme from human whole saliva by Streptococcus sanguis 903 and other oral microorganisms.

Authors:  N J Laible; G R Germaine
Journal:  Infect Immun       Date:  1982-04       Impact factor: 3.441

View more
  4 in total

1.  Inhibition of bactericidal and bacteriolytic activities of poly-D-lysine and lysozyme by chitotriose and ferric iron.

Authors:  G R Tompkins; M M O'Neill; T G Cafarella; G R Germaine
Journal:  Infect Immun       Date:  1991-02       Impact factor: 3.441

2.  Effect of lysozyme on glucose fermentation, cytoplasmic pH, and intracellular potassium concentrations in Streptococcus mutans 10449.

Authors:  Y B Wang; G R Germaine
Journal:  Infect Immun       Date:  1991-02       Impact factor: 3.441

3.  A possible role for lysozyme in determining acute exacerbation in chronic bronchitis.

Authors:  D C Taylor; A W Cripps; R L Clancy
Journal:  Clin Exp Immunol       Date:  1995-11       Impact factor: 4.330

4.  Prevention of Bacterial Contamination of a Silica Matrix Containing Entrapped β-Galactosidase through the Action of Covalently Bound Lysozymes.

Authors:  Heng Li; Shuai Li; Pu Tian; Zhuofu Wu; Zhengqiang Li
Journal:  Molecules       Date:  2017-02-28       Impact factor: 4.411

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.